📖 Your Q2 Earnings Guide: Discover the Stocks ProPicks AI Highlights to Jump Post-EarningsRead more

U.S. Stocks To Open Lower As Clinton Comments Hit Healthcare

Published 25/08/2016, 10:43

Stocks in Europe are on the back foot in early trading amidst mixed earnings from Vivendi (PA:VIV) and Ahold, and a downturn in healthcare and basic resource shares.

European healthcare stocks have been caught in the storm of another attack on price gauging in the industry from presidential hopeful Hillary Clinton. Shire (LON:SHP) and Hikma Pharmaceuticals (LON:HIK) are amongst the top fallers on the FTSE 100 whilst Qiagen (LON:0H1Z) in Germany was a top faller in the EURO STOXX 600 Health Care index.

The FTSE 350 Mining Index is off by over 2% from the open. Poorly-received earnings from Glencore (LON:GLEN) on Wednesday and lower oil prices continue to weigh on commodity-sensitive shares.

CRH (LON:CRH) is top riser in the FTSE 100 after reporting a rise in first half profits to 407m euros, raising its interim dividend and forecasting a continuation of growth trends into the second half. CRH is another company which (like the rest of us) is uncertain of the medium-term effects of Brexit, but has not seen any impact on its business so far.

US stocks look set for a lower open on Thursday ahead of durable goods and service sector data and earnings from discount stores Dollar General (NYSE:DG) and Dollar Tree (NASDAQ:DLTR) as well as Tiffany & Co (NYSE:TIF).

Top North-American dollar stores (the US version of pound shops) Dollar General and Dollar Tree report earnings on Thursday, a year on from the merger of the latter and rival Family Dollar.

Hilary Clinton’s attack on the price gauging of an allergy medicine is expected to continue to weigh on the healthcare sector. Biotechs especially, including the likes of Amgen (NASDAQ:AMGN), Biogen (NASDAQ:BIIB) and Celgene (NASDAQ:CELG) can be expected to remain under pressure. Her statements reaffirm a fear in the industry that a Clinton presidency would see a serious crackdown on pharmaceutical price gauging.

What’s setting up to be a down week for oil, after three weeks of gains, is coinciding with a pullback in US equities to the bottom of the recent price range.

USA pre-opening levels

S&P 500: 3 points lower at 2,172

Dow Jones: 26 points lower at 18,455

Nasdaq 100: 8 points lower at 4,775

Disclaimer: CMC Markets is an execution only provider. The material (whether or not it states any opinions) is for general information purposes only, and does not take into account your personal circumstances or objectives. Nothing in this material is (or should be considered to be) financial, investment or other advice on which reliance should be placed.

No opinion given in the material constitutes a recommendation by CMC Markets or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person.

Original post

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.